How has been the historical performance of Bandaram Pharma?

Answer:The historical performance of Bandaram Pharma shows a steady increase in net sales and profit over the past three years.

Breakdown:
Bandaram Pharma's net sales rose from 18.73 Cr in Mar'23 to 34.08 Cr in Mar'24, and further increased to 36.96 Cr in Mar'25. The total operating income followed the same trend, reaching 36.96 Cr in Mar'25. The total expenditure, excluding depreciation, also grew from 17.57 Cr in Mar'23 to 34.14 Cr in Mar'25. Operating profit, excluding other income, remained stable at 2.82 Cr in both Mar'24 and Mar'25, while the overall operating profit increased from 1.35 Cr in Mar'23 to 2.91 Cr in Mar'25. Profit before tax improved significantly from 0.33 Cr in Mar'23 to 1.32 Cr in Mar'25, and profit after tax also saw a rise from 0.26 Cr to 0.99 Cr in the same period. The company's total assets increased from 20.17 Cr in Mar'23 to 38.92 Cr in Mar'25, with total liabilities also rising from 20.17 Cr to 38.92 Cr. The cash flow from operating activities remained negative at -4.00 Cr in Mar'25, consistent with the previous year, while cash flow from financing activities showed a positive trend at 5.00 Cr in Mar'25. Overall, Bandaram Pharma has demonstrated growth in sales and profitability, alongside an increase in total assets and liabilities.